CM
CVS icon

Capula Management’s CVS Health CVS Stock Holding History

Capula Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$740K Buy
10,300
+6,100
+145% +$470K 0.01% 421
2025
Q4 		$333K Sell
4,200
-74,000
-95% -$5.83M ﹤0.01% 467
2025
Q3 		$5.9M Buy
78,200
+400
+0.5% +$27.4K 0.03% 140
2025
Q2 		$5.37M Buy
77,800
+76,000
+4,222% +$4.98M 0.05% 66
2025
Q1 		$122K Buy
+1,800
New +$108K ﹤0.01% 600
2024
Q1 		– Sell
-13,600
Closed -$1.07M – 497
2023
Q4 		$1.07M Sell
13,600
-59,400
-81% -$4.23M 0.04% 89
2023
Q3 		$5.1M Buy
+73,000
New +$5.17M 0.11% 94
2023
Q2 		– Sell
-255,000
Closed -$18.9M – 506
2023
Q1 		$18.9M Sell
255,000
-287,000
-53% -$24.1M 0.23% 89
2022
Q4 		$50.5M Buy
542,000
+129,100
+31% +$12.5M 0.68% 34
2022
Q3 		$39.4M Buy
412,900
+88,900
+27% +$8.8M 0.53% 38
2022
Q2 		$30M Buy
324,000
+149,000
+85% +$14.5M 0.51% 47
2022
Q1 		$17.7M Buy
175,000
+109,700
+168% +$11.5M 0.25% 88
2021
Q4 		$6.74M Sell
65,300
-172,200
-73% -$15.9M 0.14% 80
2021
Q3 		$20M Sell
237,500
-262,100
-52% -$22M 0.25% 73
2021
Q2 		$41.4M Buy
499,600
+68,500
+16% +$5.61M 0.67% 26
2021
Q1 		$32.4M Buy
431,100
+311,100
+259% +$22.7M 0.64% 38
2020
Q4 		$8.2M Buy
+120,000
New +$7.81M 0.41% 66
2020
Q3 		– Sell
-54,000
Closed -$3.51M – 181
2020
Q2 		$3.51M Sell
54,000
-47,000
-47% -$2.96M 0.12% 160
2020
Q1 		$5.99M Sell
101,000
-298,600
-75% -$19.9M 0.22% 140
2019
Q4 		$29.7M Buy
399,600
+9,200
+2% +$646K 0.63% 27
2019
Q3 		$24.6M Buy
+390,400
New +$23.1M 0.52% 43

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capula Management's CVS Position: Q1 2026 in Review

Capula Management opened a new position in CVS Health (CVS) in Q1 2026: 1,465 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #894 among its holdings. This is a return to the name: Capula Management previously reported a position in CVS as recently as Q3 2025.

Capula Management first reported a position in CVS in Q1 2020 and has held it in 15 quarters since. The position peaked at $31.5M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Capula Management held 1,465 shares of CVS Health worth $105K as of Q1 2026.
  • CVS Health was a new Capula Management position in Q1 2026.
  • CVS Health made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #894 holding.
  • Capula Management first reported a position in CVS Health in Q1 2020 and has held it in 15 quarters since.
  • Capula Management's CVS Health position peaked at $31.5M in Q4 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.